ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 외용 항진균제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다.
예상되는 성장의 원동력은 위생 상태의 악화와 기후 요인의 변화, 만성 질환의 이환율 증가, 노인 인구 증가, 외음부 칸디다증 환자의 급증, 효모균증의 발생률의 상승 등입니다. 여기에는 고급 약물전달 플랫폼 개발, 보다 비용 효율적인 최신 진단 솔루션 채택, 약물 개발 프로세스에서 인공지능 통합, AI를 활용한 진균 감염 진단 등이 있습니다.
피부질환의 유병률 증가는 향후 몇 년간의 외용 항진균제 시장의 확대를 촉진할 것으로 예측됩니다. 가한 것이 주된 원인입니다. 외용 항진균제는 진균 병원체에 대한 표적 작용을 제공해, 전신적인 노출을 최소한으로 억제해, 부작용을 경감하고, 환부의 조기 치유를 서포트하는 것으로, 이러한 증상을 치료하기 위해서 사용됩니다. 2022년 4월, 미국 전문지 American Journal of Managed Care는 40,000명의 환자 중 43%가 전년에 적어도 하나의 피부 증상을 경험하고 있다고 보고했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 외용 항진균제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 외용 항진균제 시장 : 성장률 분석
세계의 외용 항진균제 시장 실적 : 규모와 성장, 2019-2024년
세계의 외용 항진균제 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 외용 항진균제 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 외용 항진균제 시장 : 제품 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
아졸
알릴아민
에키노칸딘
폴리엔
세계의 외용 항진균약 시장 : 처방 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
크림
연고
로션
스프레이
분말
세계의 외용 항진균약 시장 : 적응증별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
피부사상균 감염증
칸디다증
백선 감염증
손톱진균증
세계의 외용 항진균제 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
약국
온라인 약국
병원 약국
약국
세계의 외용 항진균제 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
클리닉
재택 헬스케어
제약회사
세계의 외용 항진균약 시장 : 아졸 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
클로트리마졸
미코나졸
케토코나졸
플루코나졸
세계의 외용 항진균제 시장 : 알릴아민 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
테르비나핀
나프티핀
부테나핀
세계의 외용 항진균약 시장 : 에키노칸딘 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
카스포펀진
미카펀진
아니둘라펀진
세계의 외용 항진균약 시장 : 폴리엔 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
니스타틴
암포테리신 B
제7장 지역별/국가별 분석
세계의 외용 항진균약 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 외용 항진균약 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
외용 항진균제 시장 : 경쟁 구도
외용 항진균제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
GSK plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Macleods Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd.
Galderma SA
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
Cipla Limited
LUPIN LIMITED
Zydus Cadila
Glenmark Pharmaceuticals Ltd.
Alkem Laboratories Ltd.
Ipca Laboratories Ltd
Taro Pharmaceutical Industries Ltd.
Natco Pharma Ltd
Femcorp Pharma
Glamris Dermacare
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
외용 항진균제 시장(2029년) : 새로운 기회를 제공하는 국가
외용 항진균제 시장(2029년) : 새로운 기회를 제공하는 부문
외용 항진균제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Topical antifungals are medications intended for external application to treat fungal infections affecting the skin, nails, or mucous membranes. They work by either stopping fungal growth or eliminating the fungi altogether. These treatments are typically used for mild to moderate infections and help alleviate symptoms such as redness, itching, and swelling.
The key categories of topical antifungals include azoles, allylamines, echinocandins, and polyenes. Azoles act by blocking the synthesis of ergosterol, an essential component of fungal cell membranes. These drugs are available in various formulations such as creams, ointments, sprays, lotions, and powders. They are mainly used to address conditions like dermatophyte infections, candidiasis, tinea infections, and onychomycosis. Distribution channels include hospital pharmacies, retail drug stores, online pharmacies, and standard pharmacies, with end users spanning hospitals, clinics, pharmaceutical companies, and home healthcare providers.
The topical antifungals market research report is one of a series of new reports from The Business Research Company that provides topical antifungals market statistics, including the topical antifungals industry global market size, regional shares, competitors with the topical antifungals market share, detailed topical antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the topical antifungals industry. This topical antifungal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The topical antifungals market size has grown strongly in recent years. It will grow from $5.64 billion in 2024 to $6.02 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. Growth during the historical period was driven by an increase in hospital-acquired infections, growing preference for topical treatments, rising incidence of aspergillus-related infections, higher demand for antifungal therapies, and a surge in diabetes prevalence.
The topical antifungals market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%.
The projected growth is fueled by worsening hygiene conditions and changing climatic factors, increasing rates of chronic illnesses, a growing elderly population, a surge in cases of vulvovaginal candidiasis, and rising occurrences of cryptococcosis. Key trends expected in the market include the development of advanced drug delivery platforms, adoption of more cost-effective and modern diagnostic solutions, the integration of artificial intelligence in drug development processes, and AI-driven fungal infection diagnostics.
The growing prevalence of skin diseases is anticipated to drive the expansion of the topical antifungals market in the coming years. Skin diseases encompass conditions that affect the skin's health, appearance, or function, such as irritation, inflammation, or infections. This increase in skin-related issues is largely attributed to greater exposure to environmental pollutants and ultraviolet (UV) radiation, both of which can harm the skin and trigger various disorders. Topical antifungals are used to treat these conditions by offering targeted action against fungal pathogens, minimizing systemic exposure, reducing adverse effects, and supporting faster healing of affected areas. For example, in April 2022, the American Journal of Managed Care, a US-based peer-reviewed journal, reported that 43% of 40,000 patients experienced at least one skin condition in the previous year. Additionally, in March 2023, the World Health Organization estimated that around 1.8 billion people worldwide are affected by skin conditions at any given time. As a result, the rising incidence of skin diseases is expected to propel the topical antifungals market.
Key players in the topical antifungals market are developing innovative treatments, including histone deacetylase (HDAC) inhibitors, to improve therapeutic outcomes, counter antifungal resistance, and enhance drug penetration in the nail bed for treating onychomycosis. HDAC inhibitors function by blocking histone deacetylase enzymes, which remove acetyl groups from histone proteins. For instance, in January 2024, Vanda Pharmaceuticals Inc., a US-based biotechnology firm, received FDA approval for its Investigational New Drug (IND) application to study VTR-297 as a treatment for onychomycosis, a prevalent fungal nail infection. VTR-297, a small-molecule HDAC inhibitor with antifungal properties, was originally derived from the bacterial species Streptomyces hygroscopicus and was first identified as an antifungal antibiotic.
In August 2022, Avista Capital Partners, a US-based private equity firm, acquired WellSpring Consumer Healthcare for an undisclosed sum. This acquisition was part of Avista's strategy to enhance its presence in the consumer healthcare market by utilizing WellSpring Consumer Healthcare's portfolio of over-the-counter (OTC) health and wellness products. WellSpring Consumer Healthcare specializes in the development of OTC medications and antifungal treatments.
Major players in the topical antifungals market are Pfizer Inc., Bayer AG, Novartis AG, GSK plc, Fresenius Kabi AG, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd., Galderma S.A., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, LUPIN LIMITED, Zydus Cadila, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd, Taro Pharmaceutical Industries Ltd., Natco Pharma Ltd, Femcorp Pharma, Glamris Dermacare.
North America was the largest region in the topical antifungals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in topical antifungals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the topical antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The topical antifungals market consists of sales of clotrimazole, terbinafine, ketoconazole, econazole, and tolnaftate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Topical Antifungals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on topical antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for topical antifungals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The topical antifungals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Azoles; Allylamines; Echinocandins; Polyenes
2) By Formulation Type: Creams; Ointments; Lotions; Sprays; Powders
3) By Indication: Dermatophyte Infections; Candidiasis; Tinea Infections; Onychomycosis
4) By Distribution Channel: Pharmacies; Online Pharmacies; Hospital Pharmacies; Drug Stores
5) By End-User: Hospitals; Clinics; Home Healthcare; Pharmaceutical Companies
Subsegments:
1) By Azoles: Clotrimazole; Miconazole; Ketoconazole; Fluconazole
2) By Allylamines: Terbinafine; Naftifine; Butenafine
3) By Echinocandins: Caspofungin; Micafungin; Anidulafungin
4) By Polyenes: Nystatin; Amphotericin B
Companies Mentioned: Pfizer Inc.; Bayer AG; Novartis AG; GSK plc; Fresenius Kabi AG
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Topical Antifungals Market Characteristics
3. Topical Antifungals Market Trends And Strategies
4. Topical Antifungals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Topical Antifungals Growth Analysis And Strategic Analysis Framework
5.1. Global Topical Antifungals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Topical Antifungals Market Growth Rate Analysis
5.4. Global Topical Antifungals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Topical Antifungals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Topical Antifungals Total Addressable Market (TAM)
6. Topical Antifungals Market Segmentation
6.1. Global Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azoles
Allylamines
Echinocandins
Polyenes
6.2. Global Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Creams
Ointments
Lotions
Sprays
Powders
6.3. Global Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermatophyte Infections
Candidiasis
Tinea Infections
Onychomycosis
6.4. Global Topical Antifungals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacies
Online Pharmacies
Hospital Pharmacies
Drug Stores
6.5. Global Topical Antifungals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Healthcare
Pharmaceutical Companies
6.6. Global Topical Antifungals Market, Sub-Segmentation Of Azoles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clotrimazole
Miconazole
Ketoconazole
Fluconazole
6.7. Global Topical Antifungals Market, Sub-Segmentation Of Allylamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Terbinafine
Naftifine
Butenafine
6.8. Global Topical Antifungals Market, Sub-Segmentation Of Echinocandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Caspofungin
Micafungin
Anidulafungin
6.9. Global Topical Antifungals Market, Sub-Segmentation Of Polyenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nystatin
Amphotericin B
7. Topical Antifungals Market Regional And Country Analysis
7.1. Global Topical Antifungals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Topical Antifungals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
